AB2 Bio SA
Drug discovery, focused on developing therapies for the treatment of inflammatory diseases
AB2 Bio SA is a Swiss biopharmaceutical company developing “best in class” innovative therapies for the treatment of inflammatory diseases with large unmet medical needs and major market opportunities.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
27.01.2025
AB2 Bio signs USD 600 million agreement with Nippon Shinyaku (startupticker.ch)
03.03.2020
AB2 Bio prepares market entry of its lead product (startupticker.ch)
14.01.2016
AB2 Bio Ltd raises CHF 21 million in Series B financing round (startupticker.ch)
No milestones
No Jobs
No videos and documents
No Awards
AB2 Bio SA
Drug discovery, focused on developing therapies for the treatment of inflammatory diseases
Website:
www.ab2bio.com/en/home.8.html
Headquarter:
Lausanne
Foundation Date:
July 2010
Technology:
- Biotech
Sectors:
- Drug development platforms
- Drug discovery